trimethylamine has been researched along with Blood Pressure, High in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The association of total choline (TC) intake and its metabolite trimethylamine-N-oxide (TMAO) with hypertension and blood pressure (BP) has not been elucidated." | 8.12 | Association of Choline Intake with Blood Pressure and Effects of Its Microbiota-Dependent Metabolite Trimethylamine-N-Oxide on Hypertension. ( Feng, YQ; He, GD; Liu, XC; Lu, AS, 2022) |
| "Gut microbiota-dependent metabolites, in particular trimethylamine (TMA), are linked to hypertension." | 7.96 | Targeting on Gut Microbiota-Derived Metabolite Trimethylamine to Protect Adult Male Rat Offspring against Hypertension Programmed by Combined Maternal High-Fructose Intake and Dioxin Exposure. ( Chan, JYH; Chang-Chien, GP; Hou, CY; Hsu, CN; Lee, WC; Lin, S; Tain, YL; Wu, KLH; Yu, HR, 2020) |
| "Alterations of gut metabolites, such as SCFAs and trimethylamine (TMA), and microbial composition are associated with the development of hypertension." | 7.91 | Targeting on Gut Microbial Metabolite Trimethylamine-N-Oxide and Short-Chain Fatty Acid to Prevent Maternal High-Fructose-Diet-Induced Developmental Programming of Hypertension in Adult Male Offspring. ( Chang-Chien, GP; Hou, CY; Hsu, CN; Lin, S; Tain, YL, 2019) |
| "Offspring hypertension is associated with increases in the plasma TMAO concentration and oxidative stress and shifts in gut microbiota." | 5.91 | Iodomethylcholine Inhibits Trimethylamine-N-Oxide Production and Averts Maternal Chronic Kidney Disease-Programmed Offspring Hypertension. ( Chang-Chien, GP; Hou, CY; Hsu, CN; Lin, S; Tain, YL, 2023) |
| "The association of total choline (TC) intake and its metabolite trimethylamine-N-oxide (TMAO) with hypertension and blood pressure (BP) has not been elucidated." | 4.12 | Association of Choline Intake with Blood Pressure and Effects of Its Microbiota-Dependent Metabolite Trimethylamine-N-Oxide on Hypertension. ( Feng, YQ; He, GD; Liu, XC; Lu, AS, 2022) |
| "Increased levels of lactic acid, pyruvate, and TMAO may be related to the pathophysiological changes in the minor ischaemic stroke population." | 4.12 | Related factors based on non-targeted metabolomics methods in minor ischaemic stroke. ( Chen, C; Ding, L; Guo, J; Liu, H; Ma, Y; Qiao, X; Wang, J; Wang, M; Yang, T; Zhao, S, 2022) |
| "Gut microbiota-dependent metabolites, in particular trimethylamine (TMA), are linked to hypertension." | 3.96 | Targeting on Gut Microbiota-Derived Metabolite Trimethylamine to Protect Adult Male Rat Offspring against Hypertension Programmed by Combined Maternal High-Fructose Intake and Dioxin Exposure. ( Chan, JYH; Chang-Chien, GP; Hou, CY; Hsu, CN; Lee, WC; Lin, S; Tain, YL; Wu, KLH; Yu, HR, 2020) |
| "Alterations of gut metabolites, such as SCFAs and trimethylamine (TMA), and microbial composition are associated with the development of hypertension." | 3.91 | Targeting on Gut Microbial Metabolite Trimethylamine-N-Oxide and Short-Chain Fatty Acid to Prevent Maternal High-Fructose-Diet-Induced Developmental Programming of Hypertension in Adult Male Offspring. ( Chang-Chien, GP; Hou, CY; Hsu, CN; Lin, S; Tain, YL, 2019) |
| "Offspring hypertension is associated with increases in the plasma TMAO concentration and oxidative stress and shifts in gut microbiota." | 1.91 | Iodomethylcholine Inhibits Trimethylamine-N-Oxide Production and Averts Maternal Chronic Kidney Disease-Programmed Offspring Hypertension. ( Chang-Chien, GP; Hou, CY; Hsu, CN; Lin, S; Tain, YL, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 5 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Li, D | 1 |
| Lu, Y | 1 |
| Yuan, S | 1 |
| Cai, X | 1 |
| He, Y | 1 |
| Chen, J | 1 |
| Wu, Q | 1 |
| He, D | 1 |
| Fang, A | 1 |
| Bo, Y | 1 |
| Song, P | 1 |
| Bogaert, D | 1 |
| Tsilidis, K | 1 |
| Larsson, SC | 1 |
| Yu, H | 1 |
| Zhu, H | 1 |
| Theodoratou, E | 1 |
| Zhu, Y | 1 |
| Li, X | 1 |
| He, GD | 1 |
| Liu, XC | 1 |
| Lu, AS | 1 |
| Feng, YQ | 1 |
| Chen, C | 1 |
| Qiao, X | 1 |
| Guo, J | 1 |
| Yang, T | 1 |
| Wang, M | 1 |
| Ma, Y | 1 |
| Zhao, S | 1 |
| Ding, L | 1 |
| Liu, H | 1 |
| Wang, J | 1 |
| Tain, YL | 3 |
| Chang-Chien, GP | 3 |
| Lin, S | 3 |
| Hou, CY | 3 |
| Hsu, CN | 3 |
| Chan, JYH | 1 |
| Yu, HR | 1 |
| Lee, WC | 1 |
| Wu, KLH | 1 |
| Cashman, JR | 1 |
| Camp, K | 1 |
| Fakharzadeh, SS | 1 |
| Fennessey, PV | 1 |
| Hines, RN | 1 |
| Mamer, OA | 1 |
| Mitchell, SC | 1 |
| Nguyen, GP | 1 |
| Schlenk, D | 1 |
| Smith, RL | 1 |
| Tjoa, SS | 1 |
| Williams, DE | 1 |
| Yannicelli, S | 1 |
| Dolan, C | 1 |
| Shields, DC | 1 |
| Stanton, A | 1 |
| O'Brien, E | 1 |
| Lambert, DM | 1 |
| O'Brien, JK | 1 |
| Treacy, EP | 1 |
| Bamosa, AO | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of a Whole Food Based Nutritional Formulation on Trimethylamine N-oxide and Cardiometabolic Endpoints in Healthy Adults.[NCT05795946] | 45 participants (Anticipated) | Interventional | 2023-04-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for trimethylamine and Blood Pressure, High
| Article | Year |
|---|---|
Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Gastrointestinal Microbiome; Humans; Hypertension; Methy | 2022 |
Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria.
Topics: Animals; Clinical Trials as Topic; Diet; Genotype; Humans; Hypertension; Liver; Metabolic Diseases; | 2003 |
7 other studies available for trimethylamine and Blood Pressure, High
| Article | Year |
|---|---|
Association of Choline Intake with Blood Pressure and Effects of Its Microbiota-Dependent Metabolite Trimethylamine-N-Oxide on Hypertension.
Topics: Animals; Blood Pressure; Choline; Hypertension; Methylamines; Microbiota; Nutrition Surveys; Oxides; | 2022 |
Related factors based on non-targeted metabolomics methods in minor ischaemic stroke.
Topics: Biomarkers; Blood Glucose; Brain Ischemia; C-Reactive Protein; Homocysteine; Humans; Hypertension; I | 2022 |
Iodomethylcholine Inhibits Trimethylamine-N-Oxide Production and Averts Maternal Chronic Kidney Disease-Programmed Offspring Hypertension.
Topics: Animals; Female; Humans; Hypertension; Hypertrophy; Methylamines; Oxides; Pregnancy; Rats; Renal Ins | 2023 |
Targeting on Gut Microbiota-Derived Metabolite Trimethylamine to Protect Adult Male Rat Offspring against Hypertension Programmed by Combined Maternal High-Fructose Intake and Dioxin Exposure.
Topics: Animals; Diet, Carbohydrate Loading; Dioxins; Female; Fructose; Gastrointestinal Microbiome; Hyperte | 2020 |
Targeting on Gut Microbial Metabolite Trimethylamine-N-Oxide and Short-Chain Fatty Acid to Prevent Maternal High-Fructose-Diet-Induced Developmental Programming of Hypertension in Adult Male Offspring.
Topics: Acetates; Animals; Blood Pressure; Dietary Supplements; Fatty Acids, Volatile; Female; Fructose; Gas | 2019 |
Polymorphisms of the Flavin containing monooxygenase 3 (FMO3) gene do not predispose to essential hypertension in Caucasians.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Case-Control Studies; Genetic Predispositio | 2005 |
Response of the portal vein of spontaneous hypertensive rats to intracellular pH.
Topics: Ammonium Chloride; Animals; Hydrogen-Ion Concentration; Hypertension; In Vitro Techniques; Methylami | 1996 |